SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-011751
Filing Date
2022-03-25
Accepted
2022-03-25 08:40:27
Documents
19
Period of Report
2022-03-25
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K hrtx-8k_20220325.htm   iXBRL 8-K 37672
2 EX-99.1 hrtx-ex991_6.htm EX-99.1 23229
3 EX-99.2 hrtx-ex992_19.htm EX-99.2 5715
4 GRAPHIC slide-bonewelkvui.jpg GRAPHIC 279884
5 GRAPHIC slide-molg5aagsr3.jpg GRAPHIC 204815
6 GRAPHIC slide-4qt5nhhu3se.jpg GRAPHIC 389230
7 GRAPHIC gxcdj03aanm2000001.jpg GRAPHIC 23447
8 GRAPHIC slide-pskbqyx2drx.jpg GRAPHIC 345276
  Complete submission text file 0001564590-22-011751.txt   1916982

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA hrtx-20220325.xsd EX-101.SCH 5689
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE hrtx-20220325_lab.xml EX-101.LAB 19437
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hrtx-20220325_pre.xml EX-101.PRE 11585
13 EXTRACTED XBRL INSTANCE DOCUMENT hrtx-8k_20220325_htm.xml XML 3559
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

IRS No.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33221 | Film No.: 22768327
SIC: 2834 Pharmaceutical Preparations